Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) Sees Large Increase in Short Interest

Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) was the target of a significant growth in short interest in the month of February. As of February 15th, there was short interest totalling 900 shares, a growth of 800.0% from the January 31st total of 100 shares. Based on an average daily volume of 2,400 shares, the short-interest ratio is currently 0.4 days.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Price Performance

NASDAQ:HROWM traded up $0.26 during midday trading on Friday, hitting $26.70. The company’s stock had a trading volume of 188 shares, compared to its average volume of 2,839. Harrow Health, Inc. 11.875% Senior Notes due 2027 has a fifty-two week low of $25.30 and a fifty-two week high of $27.72. The firm’s 50 day moving average is $26.49 and its 200-day moving average is $26.42.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Wednesday, January 15th were issued a $0.7422 dividend. This represents a $2.97 dividend on an annualized basis and a yield of 11.12%. The ex-dividend date was Wednesday, January 15th.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Company Profile

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.